SCHEMBL655992

SCHEMBL655992

NC(=O)CC(Cc1nc2cc(Cl)ccc2[nH]1)c1ccc(Cl)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCZ Q05513 9/20 0.58
RAB9A P51151 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
SIRT1 Q96EB6 1/20 0.40
NPC1 O15118 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
F10 P00742 1/20 0.39
GABBR2 O75899 3/20 0.38
GABBR1 Q9UBS5 3/20 0.38
LMNA P02545 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP3A4 P08684 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
NFKB1 P19838 1/20 0.38
DRD3 P35462 1/20 0.38
BLM P54132 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL655698 0.91 PRKCZ (0.67) PRKCZRAB9AKDM4ENPC1
SCHEMBL655993 0.91 PRKCZ (0.67) PRKCZRAB9AKDM4EMAOAMAOB
SCHEMBL659483 0.89 PRKCZ (0.72) PRKCZRAB9AKDM4ENPC1TDP1
Hydrochloric Acid SCHEMBL657199 0.88 PRKCZ (0.71) PRKCZRAB9AKDM4ENPC1TDP1
SCHEMBL657366 0.86 PRKCZ (0.56) PRKCZRAB9AKDM4ENPC1TDP1
SCHEMBL2304297 0.83 PRKCZ (0.68) PRKCZRAB9AKDM4ENPC1GABBR2
SCHEMBL2303141 0.83 PRKCZ (0.64) PRKCZRAB9AKDM4ETDP1GABBR2
SCHEMBL655699 0.82 PRKCZ (0.76) PRKCZRAB9AKDM4ETDP1F10
Hydrochloric Acid SCHEMBL657315 0.82 PRKCZ (0.67) PRKCZRAB9AKDM4ENPC1
SCHEMBL2303676 0.82 PRKCZ (0.79) PRKCZRAB9AKDM4EGABBR2GABBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US claimed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP claimed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO claimed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP claimed
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB PRKCZ 26/4885RAB9A 2902/4885KDM4E 1893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.